U.S. Water Utilities Stock News

NasdaqGM:CRSP
NasdaqGM:CRSPBiotechs

ARK’s Bigger CRISPR Therapeutics Stake Underscores Gene Editing Pipeline Story

ARK Investment Management has significantly expanded its position in CRISPR Therapeutics (NasdaqGM:CRSP), purchasing a large block of shares. The move highlights ARK's confidence in CRISPR Therapeutics' role in gene editing and its clinical pipeline. The news coincides with continued work on gene editing therapies targeting beta thalassemia, sickle cell disease, cardiovascular conditions, and type 1 diabetes. CRISPR Therapeutics' share price recently stood at $49.96, with the stock showing...
NasdaqGS:EWBC
NasdaqGS:EWBCBanks

East West Bancorp (EWBC) Valuation After Earnings Beat And 33% Dividend Increase

East West Bancorp (EWBC) just reported stronger than expected fourth quarter results and announced a 33% increase in its quarterly dividend to $0.80 per share, a combination that sharpened the market’s focus on the stock. See our latest analysis for East West Bancorp. The latest set of results and the higher dividend come after a strong run for the stock, with a 90 day share price return of 12.64% and a 1 year total shareholder return of 13.93%. The 5 year total shareholder return of 100.36%...
NasdaqGS:CRUS
NasdaqGS:CRUSSemiconductor

Is Cirrus Logic (CRUS) Pricing Make Sense After Strong Multi‑Year Share Price Gains

If you are wondering whether Cirrus Logic shares still offer value at current levels, this article walks through what the numbers are really saying about the stock. The share price last closed at US$130.34, with returns of 2.4% over 7 days, 10.0% over 30 days, 8.9% year to date, 29.8% over 1 year and 52.7% over 5 years, which may have caught the attention of investors who follow price trends closely. Recent coverage around Cirrus Logic has focused on its role in the semiconductor space and...
NasdaqGS:DNLI
NasdaqGS:DNLIBiotechs

Assessing Denali Therapeutics (DNLI) Valuation As WORLDSymposium Data And FDA Priority Review Draw Closer

Denali Therapeutics (DNLI) is back in focus after announcing it will present clinical and preclinical data from its Enzyme Transport Vehicle programs at the 22nd Annual WORLDSymposium in early February. See our latest analysis for Denali Therapeutics. The upcoming WORLDSymposium presentations and the FDA Priority Review have arrived after a strong run in the 1 month share price, with a 30 day share price return of 31.68% and a year to date share price return of 33.62%. However, the 1 year...
NYSE:MA
NYSE:MADiversified Financial

Mastercard (MA) Earnings Growth Of 16.3% Reinforces Premium Valuation Narrative

Latest FY 2025 earnings snapshot Mastercard (MA) has wrapped up FY 2025 with Q4 revenue of US$8.8b and basic EPS of US$4.53, setting the tone for a year where trailing 12 month revenue reached US$32.8b and EPS came in at US$16.54, alongside trailing earnings growth of 16.3% year over year. Over the last six reported quarters, the company has seen quarterly revenue move from US$7.5b in Q4 2024 to US$8.8b in Q4 2025. Basic EPS over that same span has ranged from US$3.54 in Q3 2024 to US$4.53 in...
NYSE:HTH
NYSE:HTHBanks

Hilltop Holdings Ups Dividend And Buybacks As Earnings Strengthen

Hilltop Holdings (NYSE:HTH) raised its quarterly dividend by 11% following its latest full year results. The company also authorized a new US$125 million share repurchase program. These capital return actions arrive after a year of improved profitability and strong financial performance. For you as an investor, this move puts fresh attention on Hilltop Holdings, a financial services company active in banking and other related lines of business. The higher dividend and new buyback plan come...
NasdaqGS:LKQ
NasdaqGS:LKQRetail Distributors

LKQ Board Review Puts Full Sale And Business Model In Focus

LKQ's board has started a formal review of the business, including the option of selling the entire company. The process is aimed at evaluating potential changes to ownership and operations that could affect shareholders and creditors. This review follows a period of mixed share performance and comes with the stock last closing at $32.85. For investors in NasdaqGS:LKQ, this announcement comes after a stretch of uneven returns. The stock is up 8.8% over the past month and 9.4% year to date,...
NYSE:IOT
NYSE:IOTSoftware

Is It Time To Reassess Samsara (IOT) After Recent Share Price Slide?

If you are wondering whether Samsara's current share price really reflects its long term potential, you are asking the same question this article set out to tackle. The stock has seen a 12.6% decline over the last week, a 20.9% decline over the last month, a 17.3% decline year to date and a 45.5% decline over the last year, although the three year return sits at 90.7%. Recent coverage has focused on how Samsara fits into broader themes in connected operations and software as a service, with...
NasdaqGS:STX
NasdaqGS:STXTech

Is Seagate (STX) Still Attractive After A 331% One Year Surge On AI Storage Hopes

If you are wondering whether Seagate Technology Holdings is priced attractively after its huge run, this review will walk through what the current share price might be implying about value. The stock last closed at US$407.69, with returns of 17.8% over 7 days, 48.0% over 30 days, 41.8% year to date and a very large 1 year gain of 331.3%, plus multi year returns that are more than 5x over 3 and 5 years. Recent coverage has centered on Seagate's position in data storage and AI related...
NasdaqGS:RARE
NasdaqGS:RAREBiotechs

Is Ultragenyx Pharmaceutical (RARE) Pricing Reflect Its Rare Disease Pipeline Progress And Share Slump

If you are wondering whether Ultragenyx Pharmaceutical at around US$24 per share offers value or just more volatility, you are not alone. This article focuses squarely on what the current price might be implying. The stock has seen mixed returns, with a 4.7% gain over the last 30 days and a 2.0% return year to date, set against a 44.1% decline over 1 year, 47.4% over 3 years and 85.2% over 5 years. Recent news coverage around Ultragenyx has revolved around its position in the rare disease...
NYSE:TSM
NYSE:TSMSemiconductor

Assessing Taiwan Semiconductor Manufacturing (NYSE:TSM) Valuation After Strong Multi‑Period Shareholder Returns

Taiwan Semiconductor Manufacturing (NYSE:TSM) has been drawing attention after its recent share performance, with the stock showing mixed short term returns and stronger gains over the past year and the past 3 months. See our latest analysis for Taiwan Semiconductor Manufacturing. At a latest share price of $330.56, Taiwan Semiconductor Manufacturing has seen an 8.78% 1 month share price return and a 59.58% 1 year total shareholder return, suggesting that recent momentum is still aligned with...
NYSE:CMC
NYSE:CMCMetals and Mining

Is It Too Late To Reassess Commercial Metals (CMC) After Its Recent 60% One Year Rally

If you are wondering whether Commercial Metals is still attractively priced after a strong run, this article walks through what the numbers currently say about its value. The stock recently closed at US$76.87, with returns of 11.1% over the last 30 days, 7.1% year to date, 60.6% over 1 year and 41.4% over 3 years. Over the last 7 days there has been a 0.8% decline that may have caught your eye. Recent news coverage has focused on Commercial Metals as an established name in steel and metal...
NYSE:C
NYSE:CBanks

Is It Time To Reassess Citigroup (C) After Its Restructuring Progress And Share Price Rally

If you are wondering whether Citigroup at around US$115.71 is still offering value after a strong run, this article walks through what the current price really implies. Citigroup's share price shows a mixed recent picture, with a 1.9% gain over the last 7 days, a 0.8% decline over 30 days and a 2.5% decline year to date, set against a 46.0% return over 1 year, 150.8% over 3 years and 119.2% over 5 years. Recent coverage has focused on Citigroup's ongoing restructuring efforts, including...
NYSE:CB
NYSE:CBInsurance

Is Chubb (CB) Pricing Reflect Its Valuation After Recent Share Price Gains?

If you are wondering whether Chubb's current share price lines up with its underlying value, this breakdown will help you frame what you are really paying for today. The stock last closed at US$309.56, with returns of 2.9% over 7 days, a 0.8% decline over 30 days, a 0.2% decline year to date, 15.4% over 1 year, 54.0% over 3 years, and 105.7% over 5 years. Recent news coverage around Chubb has focused on its position as a major global insurer, including commentary on its underwriting...
NYSE:POR
NYSE:PORElectric Utilities

Assessing Portland General Electric (POR) Valuation After Fresh Analyst Target Upgrades

Recent analyst actions have put Portland General Electric (POR) in focus, as BTIG reiterated its buy rating alongside a higher price target, while Wells Fargo also lifted its target ahead of the company’s FY 2025 results and growth update. See our latest analysis for Portland General Electric. At a share price of $50.25, Portland General Electric has seen a 10.0% 90 day share price return and a 28.09% 1 year total shareholder return, suggesting that recent analyst updates and upcoming FY 2025...
NYSE:DBD
NYSE:DBDTech

A Look At Diebold Nixdorf (DBD) Valuation After Recent Share Price Moves

Diebold Nixdorf (DBD) has drawn investor attention after recent share moves, with the stock showing a mix of short term declines and longer term gains that prompt closer scrutiny of its fundamentals and valuation. See our latest analysis for Diebold Nixdorf. At a share price of $69.01, Diebold Nixdorf’s recent 1 day share price return of 0.49% decline and 7 day share price return of 1.43% decline sit alongside a stronger 90 day share price return of 16.67% and 1 year total shareholder return...
NYSE:NUE
NYSE:NUEMetals and Mining

Will Nucor’s (NUE) Q4 Miss but Strong 2026 Outlook Change Its Profitability Narrative

Nucor Corporation recently reported fourth-quarter 2025 results showing sales of US$7.69 billion and net income of US$378 million, alongside full-year 2025 sales of US$32.49 billion and net income of US$1.74 billion. Despite missing some analyst earnings expectations, Nucor highlighted strong order backlogs and projected earnings growth across all three operating segments for the first quarter of 2026. We’ll now examine how management’s expectation of stronger first-quarter earnings across...
NasdaqGS:DKNG
NasdaqGS:DKNGHospitality

DraftKings Confronts Prediction Market Rivals As Valuation Signals Upside Potential

DraftKings (NasdaqGS:DKNG) is facing rising competition from prediction market platforms that are attracting sports and event bettors. A major investment manager has exited its position in DraftKings, citing competitive risks tied to these prediction platforms. In response, DraftKings is launching its own prediction style products to keep users engaged and address changing customer preferences. DraftKings operates as a digital sports betting and gaming company, and it is now contending with...
NasdaqGS:HOOD
NasdaqGS:HOODCapital Markets

A Look At Robinhood Markets (HOOD) Valuation As Trump Accounts And Tokenized Stocks Gain Attention

Robinhood Markets (HOOD) is back in focus after reports that the U.S. government may tap the fintech to help oversee new children’s “Trump accounts,” while it simultaneously pushes ahead with tokenized stocks and prediction markets. See our latest analysis for Robinhood Markets. The recent headlines around potential Trump accounts, tokenized stocks and prediction markets come at a tricky moment for the shares, with a 90 day share price return of -32.23% and a 1 year total shareholder return...
NYSE:NCLH
NYSE:NCLHHospitality

Is Norwegian Cruise Line Holdings (NCLH) Pricing Reflect Recent Share Weakness Or Long Term Potential

Wondering whether Norwegian Cruise Line Holdings at around US$21.96 is a potential bargain or a value trap? This article walks through what the current price might be telling you. The stock has had a mixed run, with a 4.9% gain over the last 7 days, a 1.6% decline over 30 days, a 3.6% decline year to date, a 22.5% decline over 1 year, a 32.5% return over 3 years, and an 11.2% decline over 5 years. Recent attention around the cruise industry, including ongoing discussions on travel demand,...
NYSE:RXO
NYSE:RXOTransportation

Is RXO (RXO) Offering Value After Recent Share Price Swings And DCF Estimate Gap

If you are looking at RXO and wondering whether the current share price gives you good value, this article will walk through what the numbers are really saying about the stock. RXO's share price recently closed at US$14.58, with a 7 day return of 6.2% decline, a 30 day return of 15.3%, a year to date return of 13.6% and a 1 year return of 43.2% decline. This suggests the market's view on the company has shifted more than once over different time frames. Recent coverage around RXO has focused...
NasdaqGS:BLKB
NasdaqGS:BLKBSoftware

Blackbaud’s AI Philanthropy Links Workforce Impact With Undervalued Stock Story

Blackbaud (NasdaqGS:BLKB) announced a multi-year, six-figure major gift to Generation: You Employed. The commitment is focused on global workforce development through AI-driven training programs. The partnership is aimed at supporting economic mobility for underserved communities worldwide. The initiative aligns Blackbaud's philanthropy with its focus on responsible AI and social impact software. For investors watching NasdaqGS:BLKB, this move ties directly into the company’s role as a...